DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma
Cited by 52
Related Papers
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
|The Lancet Oncology|2019|533
Gold nanoparticles and gold nanorods in the landscape of cancer therapy
|Molecular Cancer|2023|310
Genome-Wide Association Analysis of Meat Quality Traits in a Porcine Large White × Minzhu Intercross Population
|International Journal of Biological Sciences|2012|90
WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition
|PLoS ONE|2016|56
miR‑195‑5p regulates multi‑drug resistance of gastric cancer cells via targeting ZNF139
|Oncology Reports|2018|44